搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Burkholderia sp. 3-deoxy-manno-octulosonate cytidylyltransferase 2 (kdsB2) CSB-YP659960BAAK
CSB-EP659960BAAK
CSB-BP659960BAAK
CSB-MP659960BAAK
CSB-EP659960BAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia sp. Adenylosuccinate synthetase 2 (purA2) CSB-YP659961BAAK
CSB-EP659961BAAK
CSB-BP659961BAAK
CSB-MP659961BAAK
CSB-EP659961BAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Quinolinate synthase A (nadA) CSB-YP659962GBJ
CSB-EP659962GBJ
CSB-BP659962GBJ
CSB-MP659962GBJ
CSB-EP659962GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens ATP synthase gamma chain (atpG) CSB-YP659963GBJ
CSB-EP659963GBJ
CSB-BP659963GBJ
CSB-MP659963GBJ
CSB-EP659963GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens ATP synthase subunit a (atpB), partial CSB-YP659964GBJ1
CSB-EP659964GBJ1
CSB-BP659964GBJ1
CSB-MP659964GBJ1
CSB-EP659964GBJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens NADH-quinone oxidoreductase subunit I 2 (nuoI2) CSB-YP659965GBJ
CSB-EP659965GBJ
CSB-BP659965GBJ
CSB-MP659965GBJ
CSB-EP659965GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Glutamyl-tRNA reductase (hemA) CSB-YP659966GBJ
CSB-EP659966GBJ
CSB-BP659966GBJ
CSB-MP659966GBJ
CSB-EP659966GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP659967GBJ
CSB-EP659967GBJ
CSB-BP659967GBJ
CSB-MP659967GBJ
CSB-EP659967GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial CSB-YP659968GBJ
CSB-EP659968GBJ
CSB-BP659968GBJ
CSB-MP659968GBJ
CSB-EP659968GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Dephospho-CoA kinase (coaE) CSB-YP659969GBJ
CSB-EP659969GBJ
CSB-BP659969GBJ
CSB-MP659969GBJ
CSB-EP659969GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Selenide, water dikinase (selD) CSB-YP659970GBJ
CSB-EP659970GBJ
CSB-BP659970GBJ
CSB-MP659970GBJ
CSB-EP659970GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens 50S ribosomal protein L25 (rplY) CSB-YP659971GBJ
CSB-EP659971GBJ
CSB-BP659971GBJ
CSB-MP659971GBJ
CSB-EP659971GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Glucose-1-phosphate adenylyltransferase (glgC) CSB-YP659972GBJ
CSB-EP659972GBJ
CSB-BP659972GBJ
CSB-MP659972GBJ
CSB-EP659972GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens tRNA (mo5U34)-methyltransferase (cmoB) CSB-YP659973GBJ
CSB-EP659973GBJ
CSB-BP659973GBJ
CSB-MP659973GBJ
CSB-EP659973GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Potassium-transporting ATPase C chain (kdpC), partial CSB-YP659974GBJ
CSB-EP659974GBJ
CSB-BP659974GBJ
CSB-MP659974GBJ
CSB-EP659974GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens UDP-3-O-acylglucosamine N-acyltransferase (lpxD) CSB-YP659975GBJ
CSB-EP659975GBJ
CSB-BP659975GBJ
CSB-MP659975GBJ
CSB-EP659975GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens GTPase Der (der) CSB-YP659976GBJ
CSB-EP659976GBJ
CSB-BP659976GBJ
CSB-MP659976GBJ
CSB-EP659976GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens tRNA dimethylallyltransferase (miaA) CSB-YP659977GBJ
CSB-EP659977GBJ
CSB-BP659977GBJ
CSB-MP659977GBJ
CSB-EP659977GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Phosphoglucosamine mutase (glmM) CSB-YP659978GBJ
CSB-EP659978GBJ
CSB-BP659978GBJ
CSB-MP659978GBJ
CSB-EP659978GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Exodeoxyribonuclease 7 large subunit (xseA) CSB-YP659979GBJ
CSB-EP659979GBJ
CSB-BP659979GBJ
CSB-MP659979GBJ
CSB-EP659979GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>